Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study

An industry-leading non profit institute was looking to execute a hybrid Phase II Randomized Controlled Study to determine the effectiveness of an interventional therapy.

In this case study we show how Science 37’s unified technology platform and Metasite (virtual site), helped the sponsor deliver a successful hybrid clinical trial, accelerating timeline.  Learn more about the value that this  decentralized clinical trial delivered, including:

• How partnerships played a key role in accelerated trial recruitment
• The key technology elements needed to deliver a global hybrid clinical trial
• How a virtual site model enabled seamless execution of the trial
• And more